Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RVTY compared with DYN: revenue, margins and what each company keeps, and the suppliers and customers both name
RVTY
Revvity, Inc.
Change
Mkt cap
Revenue
Revenue
DYN
Dyne Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RVTY
Revvity, Inc.
vs
DYN
Dyne Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
DYN: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RVTY, solid
DYN, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RVTY
1
VNRX
Volitionrx
supplier
Shared
0
No shared counterparties.
Only DYN
1
—
University of Mons
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
RVTY
Revvity, Inc.
Change
156.81
▼
−5.41%
· post 160.75
Mkt cap
$17.5B
Revenue
$730M
Q2 FY26
Revenue
$2.9B
FY25
DYN
Dyne Therapeutics, Inc.
Change
16.69
▼
−2.07%
· post 16.69
Closed
Oct 30 '26
Mkt cap
$3.1B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
RVTY
Revvity, Inc.
vs
DYN
Dyne Therapeutics, Inc.
156.81
▼
−5.41%
post 160.75
Price
16.69
▼
−2.07%
post 16.69
$17.5B
Mkt cap
$3.1B
Q2 FY26
$730M
Revenue
—
FY25
$2.9B
Revenue
—
Change
Change
RVTY
156.81
▼
−5.41%
vs
DYN
16.69
▼
−2.07%
Closed
Oct 30 '26